We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Biomarkers in oncology drug development
- Authors
Hodgson, Darren R.; Whittaker, Robin D.; Herath, Athula; Amakye, Dereck; Clack, Glen
- Abstract
Abstract: Biomarker measurements have become an essential component of oncology drug development, particularly so in this era of targeted therapies. Such measurements ensure that clinical studies are testing our biological hypotheses and can help make the difficult decisions required to choose which drugs to stop developing or de-prioritise. For those drugs taken forward, biomarker measurements may also help choose the appropriate dose, schedule and patient population. In this review we discuss the intrinsic properties of biological sample based efficacy measurements and how these relate to their implementation in oncology drug development by way of points to consider and examples.
- Subjects
BIOMARKERS; DRUG development; CANCER research; CANCER patients; ONCOLOGY; DRUG efficacy
- Publication
Molecular Oncology, 2009, Vol 3, Issue 1, p24
- ISSN
1574-7891
- Publication type
Article
- DOI
10.1016/j.molonc.2008.12.002